Ixensor Receives Strategic Investment From Rohto Pharmaceutical With A Separate Technology Licensing Agreement
Ixensor Receives Strategic Investment From Rohto Pharmaceutical With A Separate Technology Licensing Agreement
04/27/22, 6:00 AM
Location
iXensor Co., Ltd. (6734. TWO)
Company Info
Company
I Xensor
Location
taipei, taipei city, taiwan
Additional Info
iXensor, the pioneer of mobile health, turns smartphones into lab-grade mobile medical diagnostics. In 2017, iXensor introduced the PixoTest® Blood Glucose Monitoring System as the world's first US FDA-approved smartphone camera-based blood test. Based on the PixoTech® platform, iXensor has ventured into at-home self-testing and clinical point-of-care diagnostics across infectious diseases, women's health, diabetes, and cardiovascular diseases.